Mukka Proteins Limited (BOM:544135)
India · Delayed Price · Currency is INR 29.96
+0.03 (0.10%)
At close: Jul 4, 2025
Mukka Proteins Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2019 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2019 - 2020 |
Operating Revenue | 9,800 | 13,798 | 11,771 | 7,705 | 6,038 | Upgrade |
Other Revenue | 263.9 | 19.94 | 13.99 | 14.36 | 7.65 | Upgrade |
| 10,064 | 13,818 | 11,785 | 7,719 | 6,046 | Upgrade | |
Revenue Growth (YoY) | -27.17% | 17.25% | 52.67% | 27.68% | 9.51% | Upgrade |
Cost of Revenue | 7,747 | 11,367 | 9,429 | 6,358 | 5,144 | Upgrade |
Gross Profit | 2,317 | 2,451 | 2,356 | 1,362 | 901.62 | Upgrade |
Selling, General & Admin | 323 | 297.61 | 249.05 | 205.38 | 165.59 | Upgrade |
Other Operating Expenses | 1,046 | 1,071 | 1,227 | 655.19 | 503.37 | Upgrade |
Operating Expenses | 1,504 | 1,492 | 1,595 | 946.64 | 752.39 | Upgrade |
Operating Income | 813.33 | 959.16 | 761.01 | 414.97 | 149.23 | Upgrade |
Interest Expense | -372.5 | -189.92 | -116.21 | -75.59 | -73.27 | Upgrade |
Interest & Investment Income | - | 31.66 | 16.81 | 13.09 | 9.06 | Upgrade |
Earnings From Equity Investments | 10.68 | 31.06 | 14.6 | 10.12 | 38.21 | Upgrade |
Currency Exchange Gain (Loss) | - | 92.87 | - | 11.24 | 29.23 | Upgrade |
Other Non Operating Income (Expenses) | 151.15 | -54.23 | -27.96 | -15.4 | -1.25 | Upgrade |
EBT Excluding Unusual Items | 602.66 | 870.6 | 648.25 | 358.43 | 151.21 | Upgrade |
Gain (Loss) on Sale of Assets | - | 3.95 | -2.66 | 0.93 | 3.34 | Upgrade |
Other Unusual Items | - | - | 1.33 | - | - | Upgrade |
Pretax Income | 602.66 | 874.55 | 659.43 | 359.8 | 154.55 | Upgrade |
Income Tax Expense | 121.69 | 131.5 | 184.18 | 101.61 | 44.45 | Upgrade |
Earnings From Continuing Operations | 480.97 | 743.05 | 475.25 | 258.19 | 110.1 | Upgrade |
Minority Interest in Earnings | -16.38 | -42.53 | -34.5 | -16.11 | -20.34 | Upgrade |
Net Income | 464.59 | 700.52 | 440.75 | 242.08 | 89.76 | Upgrade |
Net Income to Common | 464.59 | 700.52 | 440.75 | 242.08 | 89.76 | Upgrade |
Net Income Growth | -33.68% | 58.94% | 82.07% | 169.70% | -31.88% | Upgrade |
Shares Outstanding (Basic) | 300 | 226 | 220 | 220 | 220 | Upgrade |
Shares Outstanding (Diluted) | 300 | 226 | 220 | 220 | 220 | Upgrade |
Shares Change (YoY) | 32.81% | 2.58% | - | - | - | Upgrade |
EPS (Basic) | 1.55 | 3.10 | 2.00 | 1.10 | 0.41 | Upgrade |
EPS (Diluted) | 1.55 | 3.10 | 2.00 | 1.10 | 0.41 | Upgrade |
EPS Growth | -50.06% | 54.94% | 82.13% | 169.61% | -31.88% | Upgrade |
Free Cash Flow | -1,360 | -1,680 | -655.62 | -17.03 | -47.28 | Upgrade |
Free Cash Flow Per Share | -4.54 | -7.45 | -2.98 | -0.08 | -0.21 | Upgrade |
Gross Margin | 23.03% | 17.74% | 19.99% | 17.64% | 14.91% | Upgrade |
Operating Margin | 8.08% | 6.94% | 6.46% | 5.38% | 2.47% | Upgrade |
Profit Margin | 4.62% | 5.07% | 3.74% | 3.14% | 1.49% | Upgrade |
Free Cash Flow Margin | -13.52% | -12.16% | -5.56% | -0.22% | -0.78% | Upgrade |
EBITDA | 948.84 | 1,068 | 879.74 | 496.42 | 232.53 | Upgrade |
EBITDA Margin | 9.43% | 7.73% | 7.46% | 6.43% | 3.85% | Upgrade |
D&A For EBITDA | 135.51 | 109.07 | 118.73 | 81.45 | 83.3 | Upgrade |
EBIT | 813.33 | 959.16 | 761.01 | 414.97 | 149.23 | Upgrade |
EBIT Margin | 8.08% | 6.94% | 6.46% | 5.38% | 2.47% | Upgrade |
Effective Tax Rate | 20.19% | 15.04% | 27.93% | 28.24% | 28.76% | Upgrade |
Revenue as Reported | 10,215 | 13,961 | 11,838 | 7,761 | 6,100 | Upgrade |
Advertising Expenses | - | - | - | 6.22 | 5.72 | Upgrade |
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.